Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Acceptability
A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms - Acceptability
1 other identifier
observational
54
2 countries
3
Brief Summary
This qualitative study will use focus groups, small group interviews, and individual interviews (both in person and over the phone) to compile a range of perspectives on service members' decision-making processes and information needs related to Stellate Ganglion Block (SGB). Participants will include service members, spouses, and providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2017
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2017
CompletedFirst Posted
Study publicly available on registry
October 5, 2017
CompletedStudy Start
First participant enrolled
November 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2018
CompletedJuly 30, 2018
July 1, 2018
4 months
September 28, 2017
July 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Participants' perceptions of SGB in relation to other options for treatment of PTSD, from the perspectives of service members or service member/spouse couples.
Discussion topic areas: * Context for mental health and treatment * Advantages and drawbacks of treatment options * Information and decision-making * Experience and expectations
Within three month of receiving one SGB study procedure for PTSD symptoms
Participants' perceptions of SGB in relation to other options for treatment of PTSD, from the perspectives of providers
Discussion topic areas: * Context for mental health and treatment * Advantages and drawbacks of treatment options * Information and decision-making * Experience and expectations
Through study completion, approximately six months
Study Arms (2)
Participants
Service members who received at least one SGB study procedure as part of the clinical effectiveness trial during the three months prior to qualitative data collection or service members who received at least one SGB for PTSD symptoms at a study site in the three months prior to qualitative data collection.
Providers
Behavioral Health or other (e.g., Family Medicine) clinicians who have referred or could potentially have referred service members for SGB for PTSD symptoms, as well as physicians who provide SGBs.
Eligibility Criteria
* participants in effectiveness clinical trial and their spouses * service members who have received SGB for PTSD symptoms at the participating study sites outside of the clinical trial and their spouse * providers who have referred or could potentially have referred patients for SGB for PTSD symptoms at the study sites * clinicians who provide SGB for PTSD
You may qualify if:
- Service members must have received at least one SGB and/or study procedure for PTSD symptoms during the past three months at a participating study site (as a participant in the clinical effectiveness trial or outside of the study).
- Clinical trial participants must have indicated willingness to participate in the qualitative study when asked by the Research Coordinator (RC) at baseline data collection.
- Non-clinical trial participants must be active-duty status.
- A service member/spouse dyad will consist of a service member meeting an above criterion and his/her spouse.
- Providers will be Behavioral Health or other (e.g., Family Medicine) clinicians who have referred or could potentially have referred service members to the study, and physicians who administer SGBs.
You may not qualify if:
- Service members will be excluded from the qualitative study if participation would cause them undue distress, in the opinion of the RC or treating clinician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RTI Internationallead
- Womack Army Medical Centercollaborator
- Tripler Army Medical Centercollaborator
- Landstuhl Regional Medical Centercollaborator
Study Sites (3)
Tripler Army Medical Center (TAMC)
Honolulu, Hawaii, 96859, United States
Womack Army Medical Center (WAMC)
Fort Bragg, North Carolina, 28310, United States
Landstuhl Regional Medical Center (LRMC)
Landstuhl, 66849, Germany
Related Publications (1)
Krueger, R.A., & M.A. Casey, M. A. (2000). Focus groups. A practical guide for applied research. Thousand Oaks, CA: Sage.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bradford B Walters, MD, PhD, MBA
RTI International
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2017
First Posted
October 5, 2017
Study Start
November 3, 2017
Primary Completion
March 2, 2018
Study Completion
March 2, 2018
Last Updated
July 30, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share